Table 1.
Brain samples used in this study
| Brain ID | Category | Age | Sex | PMI | Assay |
|---|---|---|---|---|---|
| BWH04 | LP-NCI | 53 | M | ND | MEA |
| MGH2038 | LP-NCI | 78 | F | 6 | MEA |
| MGH1887 | LP-NCI | 60 | M | ND | MEA |
| MGH2018 | LP-NCI | 92 | F | 24 | MEA |
| RM100 | LP-NCI | 88 | M | 9 | NI |
| RM105 | LP-NCI | 75 | F | 3 | NI |
| RM106 | LP-NCI | 91 | F | 15 | NI |
| BWH02 | LP-NCI | 76 | F | ND | MEA |
| MGH1837 | LP-NCI | 68 | M | 27 | MEA |
| MGH2068 | LP-NCI | 79 | F | 9 | MEA |
| RM101 | LP-NCI | 76 | M | 5 | NI |
| RM102 | LP-NCI | 82 | M | 6 | NI |
| RM103 | LP-NCI | 85 | M | 8 | NI |
| RM104 | LP-NCI | 79 | F | 18 | NI |
| RM207 | HP-NCI | 89 | F | 17 | NI |
| RM205 | HP-NCI | 83 | F | 6 | NI |
| RM208 | HP-NCI | 80 | F | 5 | MEA / NI |
| MGH1846 | HP-NCI | 92 | M | ND | MEA |
| RM201 | HP-NCI | 78 | F | 24 | NI |
| RM206 | HP-NCI | 85 | F | 12 | NI |
| RM200 | HP-NCI | 86 | M | 7 | NI |
| BWH03 | HP-NCI | 77 | M | ND | MEA |
| MGH1965 | HP-NCI | 76 | F | 48 | MEA |
| BWH01 | HP-NCI | 76 | F | ND | MEA |
| RM202 | HP-NCI | 88 | F | 12 | NI |
| RM204 | HP-NCI | 82 | F | 8 | NI |
| RM203 | HP-NCI | 86 | F | 13 | NI |
| RM209 | HP-NCI | 87 | F | 15 | NI |
| MGH1892 | AD | 67 | M | 28 | MEA |
| RM304 | AD | 87 | F | 5 | MEA / NI |
| MGH2031 | AD | 70 | F | 8 | MEA |
| RM301 | AD | 81 | M | 12 | NI |
| RM305 | AD | 87 | F | 10 | MEA / NI |
| ALB01 | AD | 68 | F | 18 | MEA / NI |
| MGH2037 | AD | 73 | F | 22 | MEA |
| MGH2039 | AD | 74 | M | 24 | MEA |
| RM303 | AD | 87 | F | 17 | NI |
| RM306 | AD | 90 | F | 5 | NI |
| RM302 | AD | 89 | M | 4 | NI |
| RM307 | AD | 91 | F | 7 | NI |
| RM308 | AD | 98 | F | 7 | NI |
| MGH1168 | AD | 89 | F | ND | NA |
| RM300 | AD | 85 | M | 5 | NI |
Postmortem prefrontal cortex was acquired from 43 individuals. Listed are category, age at death, postmortem interval (PMI), sex, and assay(s) in which the samples were used. Due to limited supply brain tissue for many of the samples, most were used in only 1 of the 2 assays.
Abbreviations: LP-NCI low pathology and non-cognitively impaired, HP-NCI high pathology and non-cognitively impaired, AD Alzheimer’s disease, ND not determined/not known, M male, F female, MEA multi-electrode array spontaneous activity assay, NI neurite integrity assay.